Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, , , and . International Journal of Antimicrobial Agents, 55 (5): 105938 (2020)Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards, , , , , , , and . European Journal of Clinical Microbiology & Infectious Diseases, 39 (6): 1059--1061 (Jun 1, 2020)Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world, , , , , , , , , and 4 other author(s). New Microbes and New Infections, (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , and 33 other author(s). Travel Medicine and Infectious Disease, (2020)Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates, , , , , , , and . Clinical Infectious Diseases, (2020)SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects, , , , , , , and . bioRxiv, (2022)Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study, , , , , , , , , and 19 other author(s). Travel Medicine and Infectious Disease, (2020)This is the second Marseille study.Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study, , , , , , , , , and 18 other author(s). International Journal of Infectious Diseases, (2021)